The wound closure devices market size is projected to reach US$ 17.46 billion by 2031 from US$ 11.86 billion in 2024. The market is expected to register a CAGR of 5.8% during 2025–2031. The Shift Toward Minimally Invasive Wound Closing Methods is likely to bring in new market trends during the forecast period.
With an increasing number of surgeries, including C-sections, orthopedic procedures, and plastic surgeries, the demand for efficient and effective wound closure products is also growing across the world. Appropriate wound closure methods facilitate proper healing and reduce complications. As per the Eurostat, in 2022, cesarean section procedures were performed at least 1.10 million times in the European Union. A total of 230,200 cesarean sections were performed in Germany, while the procedures performed in France, Italy, and Poland ranged between 125,400 and 150,700. As per the same source, hip replacements were performed 326.2 times per 100 000 inhabitants in Germany in 2022, and the number was between 282 and 302 per 100 000 inhabitants in Austria, Denmark, and Belgium; these were the highest frequencies among the EU countries.
Wound closure devices such as sutures, staples, and newer adhesive strips assist in achieving improved results by facilitating quicker healing, lowering infection risks, and enhancing the cosmetic outcome post operation. The growing number of surgeries in developing and developed countries, combined with advances in healthcare technology, is boosting the demand for innovative closure solutions for wounds. Owing to the abovementioned factors, hospitals and specialty clinics are spending more on high-quality devices for wound closure.
The wound closure devices market is rapidly expanding due to the surge in surgical procedures and technological advances in wound closure devices. Prominent players operating in the market are focusing on innovations and collaborative efforts for enhanced product availability and reach. However, the high price of advanced wound closure devices hinders market growth.
Technological advances are significantly contributing to the wound closure devices market. Advances like bioresorbable sutures, advanced technology tissue adhesives, and improved design surgical staplers offer greater functionality and ease of use for surgeons. These devices reduce complications associated with traditional wound closure methods, such as infection, scarring, and delayed healing. Intelligent sutures that monitor healing and release drugs into the wound are a highly anticipated innovation in the market. Massachusetts Institute of Technology announced in 2023, that it has developed tissue-derived smart sutures, which can not only hold tissue in place but also detect inflammation and release drugs.
Minimally invasive techniques of wound closure are also gaining popularity as they ensure faster recovery, minimal scarring, and fewer complications. For instance, stapling and skin adhesives that result in healing at a faster rate with less damage to tissues are widely used nowadays. In May 2024, Ethicon launched echelon linear cutter, a first-of-its-kind surgical stapler that delivered 47% fewer leaks at the staple line to help reduce surgical risks.
As the healthcare industry places greater emphasis on accuracy and patient-centered therapy, applications for these next-generation wound closure technologies will increase over the next several years, setting technological innovation among the strongest influences in driving growth in the industry. Smart materials and enhanced biocompatibility are also factors contributing to the market, enabling devices for wound closure to become both more efficient as well as more patient friendly.
The growing number of chronic disease cases, including diabetes and cardiovascular diseases, presents a major opportunity for the wound closure devices market. Chronic diseases tend to cause complications that may necessitate surgeries or prolonged wound care. For instance, diabetic patients are likely to develop chronic wounds, including diabetic ulcers, which require appropriate care and closure devices for healing. As per the University of Michigan Health, in the US, diabetic foot ulcer is prevalent among 15% of diabetic patients, and ~14–24% of patients with diabetes who develop a foot ulcer undergo an amputation procedure. Moreover, the increasing number of trauma cases such as burns, accidents, and injuries is fueling the demand for effective wound care solutions. As per the US Department of Transportation, in 2021, ~43,230 people were killed in motor vehicle crashes, including 7,388 pedestrians. Wound closure devices form an essential part of the treatment of these conditions, providing quicker healing, minimizing infection risk, and enhancing overall patient outcomes. With a growing population of older people who are more susceptible to chronic conditions and a rise in the incidence of trauma cases, healthcare professionals prefer sophisticated wound closure solutions to meet these demands. As a result, market players continuously emphasize innovations specific to chronic wounds and trauma, which will likely generate significant growth opportunities for them in the long term.
Key segments that contributed to the derivation of the wound closure devices market analysis are product, wound type, and end user.
The geographic scope of the wound closure devices market report mainly focuses on five regions: North America, Asia Pacific, Europe, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the market in 2024. It is expected to continue its dominance in the global market during the forecast period. The US is the largest market for wound closure devices in the world. Chronic wounds associated with diabetes include foot, venous, and pressure ulcers. According to The International Journal of Tissue Repair and Regeneration, active or healed venous ulcers occur in 1% of the US population. As per the National Diabetes Statistics Report 2020, a publication of the Centers for Disease Control and Prevention (CDC), 34.2 million people of all ages in the US have diabetes, and ~1 million diabetics develop a foot ulcer each year, while 6-7 million diabetes patients develop ulcers in their lifetime. Thus, the rising incidence of diabetes and chronic wounds leads to an increase in demand for wound dressing and contributes to the wound closure devices market growth during the forecast period. Companies in the US are focused on expanding their presence by adopting organic and inorganic strategies. In October 2021, Medline Industries announced an investment of US$ 77.5 million to build a new distribution center in Kansas.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 11.86 Billion |
| Market Size by 2031 | US$ 17.46 Billion |
| Global CAGR (2025 - 2031) | 5.8% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The wound closure devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. Below are a few of the key developments witnessed in the wound closure devices market:
The "Wound Closure Devices Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
The List of Companies - Wound Closure Devices Market
North America dominated the market in 2024.
An upsurge in surgical procedures and technological advancements in wound closure devices are among the most significant factors fueling the market growth.
The shift toward minimally invasive wound-closing methods is likely to emerge as a new growth trend in the market in the coming years.
B Braun SE:Johnson & Johnson; Medtronic Plc; 3M Co; Stryker Corp; Baxter International Inc; Meril Life Sciences Pvt Ltd; CooperSurgical, Inc; Smith & Nephew Plc; TI Medical; Futura Surgicare Pvt Ltd (Dolphin Sutures); Corza Medical GmbH; Essity AB; Advanced Medical Solutions Group plc; Healthium Medtech Limited are among the key players operating in the market.
The market value is expected to reach US$ 17.46 billion by 2031.
The market is expected to register a CAGR of 5.8% during 2025–2031.